Filing metadata

Accession number
0001127602-20-024043
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Aug 21, 2020
Reporting period
Aug 20, 2020
Description
Insider transaction

Explore SEC Filings Hub